Pediatric Dermatology

Dupilumab provides option for severe AD in younger children
October 21, 2020

In a recent phase 3 trial, dupilumab (Dupixent, Sanofi and Regeneron) demonstrated positive results in itch reduction, skin clearance and quality-of-life. Indicating the biologic as a viable treatment option for severe atopic dermatitis in younger children.

FDA expands golimumab indication
October 02, 2020

The U.S. FDA has approved to expand the indication for golimumab (SIMPONI ARIA, Janssen Pharmaceutical Companies of Johnson & Johnson) to include it was a treatment for active psoriatic arthritis (PsA) in pediatric patients 2 years and older.

Treatment challenges with young skin of color patients
September 30, 2020

In the final part of our interview with Candrice Heath, M.D., she discusses some of the treatment challenges associated with treating pediatric patients with skin of color and how to overcome these obstacles.

Common skin conditions in pediatric skin of color patients
September 29, 2020

In part two of our interview with Candrice Heath, M.D., she explains the most commonly encountered skin conditions when treating young skin of color patients.

Tips and tricks for treating young skin of color patients
September 28, 2020

Candrice Heath, M.D., shares her tips and tricks for treating young skin of color patients from her presentation at the 2020 Skin of Color Update.

Identifying dermatologic conditions in pediatric patients with COVID-19
September 23, 2020

A recent article suggests physicians should be on the lookout for various dermatologic manifestations in pediatric patients suspected of having COVID-19.

The Cutaneous Connection: Episode 7- Tips and Tricks for Treating Young Skin of Color Patients
September 17, 2020

In this episode, Candrice Heath, M.D., sits down to discuss her recent presentation at the 2020 Skin of Color Update about clinical pearls for kids, tweens and teens with skin of color. Dr. Heath also explains the most common skin conditions for this patient group, treatment challenges, and much more.

The Cutaneous Connection: Episode 5- Becoming a Pediatric Dermatologist
August 20, 2020

This episode discusses how to become a pediatric dermatologist, including the associated benefits, compensation and responsibilities with Heather Brandling-Bennett, M.D.

FDA approves ustekinumab for pediatric psoriasis
August 07, 2020

The U.S. Food and Drug Administration has approved IL-12/IL-23 inhibitor ustekinumab (Stelara, Janssen Pharmaceutical Companies of Johnson & Johnson) for treatment of moderate-to-severe plaque psoriasis in pediatric patients 6-11 years.

EC approves secukinumab for pediatric psoriasis
August 04, 2020

The European Commission has approved secukinumab (Cosentyx, Novartis) for treatment of moderate-to-severe plaque psoriasis in pediatric patients 6